Analyst Ratings for Merrimack Pharmaceuticals (MACK)

MACK Rating Summary

  |   Expand Research on MACK
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.3 / 10   Percentile Rank: 66%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/25/2018 JPMorgan N/A Downgrade Underweight
(Neutral)		 6.00
(14.00)		 12.07
(15.13)		 25.35% Details
8/5/2016 TD Cowen N/A Downgrade
(Buy)		 N/A
(N/A)		 5.92
(15.13)		 155.57% Details